Try GOLD - Free
Weight loss cure Mounjaro is India's new drug market king
Mint Hyderabad
|November 08, 2025
Drug unseats the previous best-selling antibiotic Augmentin, which had sales of ₹80 crore
Sales of Eli Lilly’s blockbuster weight-loss drug Mounjaro have soared in India, making it the top-selling brand in October, just six months after its launch in the world's most populous nation.
The drug registered sales of ₹100 crore in October, unseating the previous bestselling antibiotic Augmentin, which recorded sales of ₹80 crore during the month, according to data from intelligence platform Pharmarack on Friday. Since its launch late in March 2025, Mounjaro's total sales have reached ₹333 crore.
Augmentin, the London-headquartered GSK’s broad-range antibiotic, still retains its top position on a moving annual total (MAT) basis, with sales of ₹863 crore in 12 months to October 2025. MAT refers to total sales seen over the latest 12-month period.
This marks Eli Lilly's sharp capture of India’s nascent anti-obesity market, outpacing competitor Novo Nordisk. ‘The brand took the second spot in sales in September, Pharmarack data showed.
This story is from the November 08, 2025 edition of Mint Hyderabad.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Hyderabad
Mint Hyderabad
Kwatra, Intel CEO talk chips, Al plans
India's ambassador to the US Vinay Mohan Kwatra discussed with Intel chief executive officer (CEO) Lip Bu Tan the company's semiconductor and artificial intelligence (AI) initiatives and plans in India.
1 min
November 10, 2025
Mint Hyderabad
Can beneficiaries of inequality be the ones who end it?
There is a kind of person the Western press often profiles with the headline: “The Meaning of... (name here).” Zohran Mamdani is that person.
4 mins
November 10, 2025
Mint Hyderabad
NCLT okays Maruti merger with Guj unit
The National Company Law Tribunal (NCLT) has approved the scheme of amalgamation in which Suzuki Motor Gujarat is being merged with its parent entity Maruti Suzuki India Ltd, the country's largest carmaker.
1 min
November 10, 2025
Mint Hyderabad
Plunge in Asia’s AI shares sows doubts over rally
The region's sharpest decline since April has been triggered by a tech-led selloff on Wall Street.
2 mins
November 10, 2025
Mint Hyderabad
Smart-beta funds aim for smarter returns, but do they really deliver?
The funds mix rules and market insights, offering diversification but not assured gains. Here's how to use them
4 mins
November 10, 2025
Mint Hyderabad
Advent to scale up luxury hotel growth
Advent Hotels International Ltd, the hospitality arm carved out of Valor Estate Ltd (formerly DB Realty), will list as a separate entity on the stock exchanges on 13 November, as it seeks to build a portfolio of luxury and upscale hotels across major Indian cities through a partnership route, an executive said.
1 min
November 10, 2025
Mint Hyderabad
Hyundai India eyes homegrown play as rivals turn up heat
Korea's Hyundai Motor that made an aggressive India bet late last century is looking to reinvent itself as a homegrown carmaker, at a time when its coveted market position is under challenge from fierce local rivals.
1 min
November 10, 2025
Mint Hyderabad
Manipal eyes Dec IPO filing, ₹1 tn valuation
IPO to see primary and secondary fundraising of more than $1 billion
2 mins
November 10, 2025
Mint Hyderabad
Govt okays 1.5mt sugar exports for season
The export allocation is lower than the 2 mt demanded by industry.
1 min
November 10, 2025
Mint Hyderabad
Bond yields are flashing amber about the future
Their rise globally despite rates being cut suggests investors are sceptical about growth. Also, central banks may have reason to ponder about what these defiant moves mean for policy
2 mins
November 10, 2025
Listen
Translate
Change font size